Chronic Myeloproliferative Disorders Completed Phase 1 / 2 Trials for Beclomethasone dipropionate (DB00394)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00010283Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonSupportive Care